RE:Will go back to sleeping mode soon There is clearly someone bidding stock down here. The company has been active in the USA from what I'm told.
Rova-T comes to mind...
Abbvie doing pretty good post Covid. Embarrassing loss attached to this drug.
Reason for stage 3 clinical failure? Off-Target Toxicity.
APC's Conjugation Linker Tech specifically materially improves off-target toxicity.
By being able to deliver the toxin more complete and directly to the cancer cell. APC's delivery method allows for a smaller dose to achieve the same result. While delivering less likelihood of healthy cell damage from the off-target toxicity.
When it comes to lung cancer. It's extremely important to be able to kill cancer, without killing your lungs.
$APC gets in bed with AbbVie or their investment partners to achieve this. This stock will start looking like Trillium Therapeutics.
Ben wants to drive Lambo's. This company is his ticket to that lifestyle if he succeeds. Can he win the game? I think he can, so happily I am a large shareholder.